Greater China Sector Update | Healthcare The sector experienced a fruitful year of innovation in 2025, and we expect globalisation and improving operating efficiency to continue to drive rapid earnings growth for drug innovators and CRO leaders from 2026 onwards. Seeing strong online demand, internet healthcare players are likely to sustain solid revenue and earnings expansion in 2026. We also anticipate that domestic medical device manufacturers will experience a gradual sales growth recove...
Sector Update | Mining Nickel prices rebounded above US$18,000/tonne on proposed 2026 RKAB quota cuts and approval delays, though sustainability remains uncertain without consistent supply discipline. Integrated players will benefit the most due to captive smelters and higher earnings sensitivity. Despite the near-term surplus, balances will tighten towards 2029. Maintain MARKET WEIGHT; HRUM is our top pick, with ANTM advantaged as an SoE. Highlights • Nickel prices rebounded but sustainability...
Sector Update | Mining Nickel prices rebounded above US$18,000/tonne on proposed 2026 RKAB quota cuts and approval delays, though sustainability remains uncertain without consistent supply discipline. Integrated players will benefit the most due to captive smelters and higher earnings sensitivity. Despite the near-term surplus, balances will tighten towards 2029. Maintain MARKET WEIGHT; HRUM is our top pick, with ANTM advantaged as an SoE. Technical Analysis Perusahaan Gas Negara | PGAS IJ Trad...
Indonesia Company Results | Aneka Tambang (ANTM IJ/BUY/Rp3,100/Target: Rp3,500) ANTM’s 3Q25 net profit fell 50.2% qoq to Rp1.28t on weaker gold and nickel sales, but 9M25 profit rose 167.9% yoy to Rp5.97t, beating expectations. We adjust 2025-26 forecasts on revised gold and nickel assumptions, and expect a volume recovery after the Grasberg suspension in 2H26. Maintain BUY with a lower target price of Rp3,500. Malaysia Company Results | Alpha IVF (ALPHA MK/BUY/RM0.34/Target: RM0.43) Earnings c...
Company Results | Aneka Tambang (ANTM IJ/BUY/Rp3,100/Target: Rp3,500) ANTM’s 3Q25 net profit fell 50.2% qoq to Rp1.28t on weaker gold and nickel sales, but 9M25 profit rose 167.9% yoy to Rp5.97t, beating expectations. We adjust 2025-26 forecasts on revised gold and nickel assumptions, and expect a volume recovery after the Grasberg suspension in 2H26. Maintain BUY with a lower target price of Rp3,500. Highlights • Following the temporary suspension of the Grasberg mine, we expect gold sales vol...
Company Results | Aneka Tambang (ANTM IJ/BUY/Rp3,100/Target: Rp3,500) ANTM’s 3Q25 net profit fell 50.2% qoq to Rp1.28t on weaker gold and nickel sales, but 9M25 profit rose 167.9% yoy to Rp5.97t, beating expectations. We adjust 2025-26 forecasts on revised gold and nickel assumptions, and expect a volume recovery after the Grasberg suspension in 2H26. Maintain BUY with a lower target price of Rp3,500. Technical Analysis Mitra Adiperkasa | MAPI IJ Trading Buy Range: We have a technical Buy at Rp...
• ANTM’s 2H25 production is set to slow on supply constraints, with 2025 gold sales guided at about 43.8 tonnes (similar to 2024 level) and nickel ore at around 16m wmt. • We maintain BUY with a lower target price of Rp4,000 (from Rp4,600), as near-term headwinds are outweighed by gold proxy positioning, upside from persistently high gold prices, and a solid long-term outlook.
Strategy: Impact Of Cabinet Reshuffle There are changes in the formation of ministers, with the Minister of Finance being a notable replacement. Share prices for big banks go down while cigarette stocks are up. The 2026 budget outlook and fiscal stance are key catalysts. Company Update | Aneka Tambang (ANTM IJ/BUY/Rp3,610/Target: Rp4,000) ANTM’s 2H25 production is set to slow on supply constraints, with 2025 gold sales guided at about 43.8 tonnes (similar to 2024 level) and nickel ore at arou...
Greater China Economics | Trade China’s export momentum softened in August as front-loaded US demand has faded, exposing the vulnerability of shipments to the US market. While the trade diversion supported flows to ASEAN and the EU, overall growth moderated. Imports also weakened amid subdued agricultural demand, despite firmer commodity-related inflows. Pro...
GREATER CHINA Results CSPC Pharmaceutical Group (1093 HK/BUY/HK$10.51/Target: HK$12.00) 1H25: Results miss; expects hoh sales recovery and two more BD deals in 2H25. Ganfeng Lithium (1772 HK/BUY/HK$30.80/Target: HK$40.00) 2Q25: Net loss in line; 3Q25 turnaround on the back of lithium carbonate price recovery. Maintain BUY, target price: HK$40.00. Li Ning (2331 HK/HOLD/HK$19.70/Target: HK$18.90) 1H25: Results beat but challenges remain in 2H25; fa...
Indonesia plans to launch its first gold ETF in 4Q25, led by IDX and OJK, to channel culturally accepted gold investment into a regulated digital investment product. Strong retail appetite, as seen in BRIS and Pegadaian’s gold growth, underpins a potential AUM expansion. As one of the largest gold producers in the world, Indonesia can source bullion locally and integrate domestic miners, Pegadaian, BRIS, refiners (ANTM) and banks into an ecosystem, creating a virtuous circle across the value cha...
GREATER CHINA Strategy Alpha Picks: July Conviction Calls Add CATL, KE Holdings, Longfor, Midea Group, Tencent and TME to our BUY list. Take profit on Prudential. Sector Online Games Upcoming new game releases to capitalise on the summer holiday season. INDONESIA Strategy Alpha Picks: Good Performances In June Our new alpha picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA...
Our Jun 25 portfolio outperformed the JCI and LQ45 by +5.1%/+7.1% respectively, mainly driven by DKFT (+16% performance) and outperformances by other stocks such as ANTM, CMRY and AMRT. Several major events to watch out this month include upcoming IPOs (especially the sizeable Chandra Daya Investasi (CDIA) IPO worth about US$143m) and the outcome of the US-Indo reciprocal tariffs discussion on 9 July. Our new Alpha Picks are ANTM, BBCA, ERAA, ICBP, MYOR, MIKA, AMRT and TLKM.
GREATER CHINA Sector Insurance Weighing the risks and returns. Update Sunny Optical (2382 HK/BUY/HK$65.15/Target: HK$100.00) Takeaways from 2025 Investor Day. Maintain BUY. INDONESIA Strategy Challenging Macro Environment Adds To Case For Rate Cut Our top picks are BBCA, BBRI, ANTM, AMRT, ICBP, CMRY and ERAA. MALAYSIA Sector Automobile ...
The JCI rebounded to about 7,000 after bottoming out at 5,968 on 9 April, following a series of developments including corporate buyback announcements, the creation of Danantara, and market anticipation of a BI rate cut which materialised on 21 May (25bp cut). Catalysts to monitor in 2H25 include: a) further BI rate cut(s), b) a slowdown in SRBI reissuance which would free up banking liquidity, c) further government economic stimulus measures, and d) heavier government spending.
The JCI rebounded to about 7,000 after bottoming out at 5,968 on 9 April, following a series of developments including corporate buyback announcements, the creation of Danantara, and market anticipation of a BI rate cut which materialised on 21 May (25bp cut). Catalysts to monitor in 2H25 are further rate BI cut(s), a slowdown in SRBI reissuance which would free up banking liquidity, further government economic stimulus measures, and heavier government spending. • In need of a rate cut and an in...
We met with 12 investors in Kuala Lumpur, and the overall tone among Malaysian-based funds can be best described as cautious but engaged. Indonesia remains firmly on their radar, but several overhangs persist, particularly around the evolving political landscape, policy clarity, the free meal programme and weak purchasing power. 2H25 government spending and a further rate cut are catalysts, in our view. Our year-end target for the JCI is 7,500.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.